Named “Operation Warp Speed”, the program will operate on the basis of collaboration between private pharmaceutical companies, civilian and military government agencies in an effort to try to reduce the period of vaccine development by eight months, according to acquaintances. about this project.
Within the organization, taxpayers, not pharmaceutical companies, will bear most of the financial risks of failure.
The goal of the project is to make 300 million doses of the vaccine available by January, according to a Washington administration official. There is no precedent for the rapid development of a vaccine.
President Donald Trump's top medical advisers, led by Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, have repeatedly said that a coronavirus vaccine will not be available for less than 12-18 months. Until then, the White House's policy calls for maintaining social distancing measures with negative economic effects, even if more normal activities in society and business will resume in the United States.
Last month, Donald Trump asked Secretary of Health and Human Services Alex Azar to speed up the development of a vaccine, and Washington administration officials have been discussing the plan for three to four weeks. Michael Caputo, a spokesman for the Department of Health and Human Services, said the US president refused to accept the standard period for developing a vaccine, encouraging a speedy procedure.
The plan provides for rapid animal testing of the world's most promising experimental vaccines, followed by coordinated human clinical trials. Vaccines that will generate the greatest prospects will enter the tests on a large scale at the same time as the launch of mass production. The project will cost billions of dollars.
According to the World Health Organization, there are at least 70 different vaccines being developed by pharmaceutical companies or research institutes. But the main companies have not joined forces in the way the project will be carried out in the USA.
Follows Mediafax on Instagram to see spectacular images and stories from around the world!
The content of the website www.mediafax.ro is intended exclusively for your personal information and use. It is prohibited republishing the content of this site in the absence of an agreement from MEDIAFAX. To obtain this agreement, please contact us at firstname.lastname@example.org.